This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnosis and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnosis and Therapy. This report contains market size and forecasts of Prostate Cancer Diagnosis and Therapy in global, including the following market information:
Global Prostate Cancer Diagnosis and Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Diagnosis and Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hormone Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnosis and Therapy include AbbVie, Astellas Pharma, AstraZeneca, Bayer, Dendreon Pharmaceuticals, Ferring, Ipsen Pharma, Johnson and Johnson and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Diagnosis and Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnosis and Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Diagnosis and Therapy Market Segment Percentages, by Type, 2022 (%)
Hormone Therapy
Chemotherapy
Biologic Therapy
Targeted Therapy
Global Prostate Cancer Diagnosis and Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Diagnosis and Therapy Market Segment Percentages, by Application, 2022 (%)
General Hospitals
Specialty Clinics
Global Prostate Cancer Diagnosis and Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Diagnosis and Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnosis and Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Diagnosis and Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Astellas Pharma
AstraZeneca
Bayer
Dendreon Pharmaceuticals
Ferring
Ipsen Pharma
Johnson and Johnson
Sanofi
Tolmar Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Diagnosis and Therapy, market overview.
Chapter 2: Global Prostate Cancer Diagnosis and Therapy market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Diagnosis and Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Diagnosis and Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnosis and Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnosis and Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnosis and Therapy Overall Market Size
2.1 Global Prostate Cancer Diagnosis and Therapy Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Diagnosis and Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnosis and Therapy Players in Global Market
3.2 Top Global Prostate Cancer Diagnosis and Therapy Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnosis and Therapy Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnosis and Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnosis and Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnosis and Therapy Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnosis and Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnosis and Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Diagnosis and Therapy Market Size Markets, 2022 & 2029
4.1.2 Hormone Therapy
4.1.3 Chemotherapy
4.1.4 Biologic Therapy
4.1.5 Targeted Therapy
4.2 By Type - Global Prostate Cancer Diagnosis and Therapy Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnosis and Therapy Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Diagnosis and Therapy Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnosis and Therapy Market Size, 2022 & 2029
5.1.2 General Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Prostate Cancer Diagnosis and Therapy Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnosis and Therapy Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Diagnosis and Therapy Revenue, 2024-2029
5.2.3 By Application - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnosis and Therapy Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Diagnosis and Therapy Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnosis and Therapy Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Diagnosis and Therapy Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnosis and Therapy Revenue, 2018-2029
6.3.2 US Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnosis and Therapy Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.4.3 France Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnosis and Therapy Revenue, 2018-2029
6.5.2 China Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.5.6 India Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnosis and Therapy Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnosis and Therapy Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Diagnosis and Therapy Market Size, 2018-2029
7 Prostate Cancer Diagnosis and Therapy Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.1.4 AbbVie Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.2.4 Astellas Pharma Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.3.4 AstraZeneca Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.4.4 Bayer Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Dendreon Pharmaceuticals
7.5.1 Dendreon Pharmaceuticals Company Summary
7.5.2 Dendreon Pharmaceuticals Business Overview
7.5.3 Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.5.4 Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.5.5 Dendreon Pharmaceuticals Key News & Latest Developments
7.6 Ferring
7.6.1 Ferring Company Summary
7.6.2 Ferring Business Overview
7.6.3 Ferring Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.6.4 Ferring Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.6.5 Ferring Key News & Latest Developments
7.7 Ipsen Pharma
7.7.1 Ipsen Pharma Company Summary
7.7.2 Ipsen Pharma Business Overview
7.7.3 Ipsen Pharma Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.7.4 Ipsen Pharma Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.7.5 Ipsen Pharma Key News & Latest Developments
7.8 Johnson and Johnson
7.8.1 Johnson and Johnson Company Summary
7.8.2 Johnson and Johnson Business Overview
7.8.3 Johnson and Johnson Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.8.4 Johnson and Johnson Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.8.5 Johnson and Johnson Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.9.4 Sanofi Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Tolmar Pharmaceuticals
7.10.1 Tolmar Pharmaceuticals Company Summary
7.10.2 Tolmar Pharmaceuticals Business Overview
7.10.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.10.4 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.10.5 Tolmar Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Diagnosis and Therapy Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnosis and Therapy Market Drivers in Global Market
Table 3. Prostate Cancer Diagnosis and Therapy Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnosis and Therapy in Global Market
Table 5. Top Prostate Cancer Diagnosis and Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Diagnosis and Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Diagnosis and Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Diagnosis and Therapy Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnosis and Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnosis and Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Prostate Cancer Diagnosis and Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Diagnosis and Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Prostate Cancer Diagnosis and Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Diagnosis and Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2024-2029
Table 30. AbbVie Company Summary
Table 31. AbbVie Prostate Cancer Diagnosis and Therapy Product Offerings
Table 32. AbbVie Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Key News & Latest Developments
Table 34. Astellas Pharma Company Summary
Table 35. Astellas Pharma Prostate Cancer Diagnosis and Therapy Product Offerings
Table 36. Astellas Pharma Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Astellas Pharma Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Prostate Cancer Diagnosis and Therapy Product Offerings
Table 40. AstraZeneca Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Prostate Cancer Diagnosis and Therapy Product Offerings
Table 44. Bayer Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. Dendreon Pharmaceuticals Company Summary
Table 47. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product Offerings
Table 48. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Dendreon Pharmaceuticals Key News & Latest Developments
Table 50. Ferring Company Summary
Table 51. Ferring Prostate Cancer Diagnosis and Therapy Product Offerings
Table 52. Ferring Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Ferring Key News & Latest Developments
Table 54. Ipsen Pharma Company Summary
Table 55. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Product Offerings
Table 56. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Ipsen Pharma Key News & Latest Developments
Table 58. Johnson and Johnson Company Summary
Table 59. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Product Offerings
Table 60. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson and Johnson Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Prostate Cancer Diagnosis and Therapy Product Offerings
Table 64. Sanofi Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Tolmar Pharmaceuticals Company Summary
Table 67. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product Offerings
Table 68. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Tolmar Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Diagnosis and Therapy Segment by Type in 2022
Figure 2. Prostate Cancer Diagnosis and Therapy Segment by Application in 2022
Figure 3. Global Prostate Cancer Diagnosis and Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnosis and Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnosis and Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnosis and Therapy Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
Figure 16. US Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
Figure 28. China Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. AbbVie Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astellas Pharma Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Ferring Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
